Lack of association of functional cathechol-O-methyltransferase gene polymorphism in schizophrenia

This publication has 25 references indexed in Scilit:

• Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders
  Pharmacogenetics, 1996
• No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity
  American Journal of Psychiatry, 1996
• Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking
  Nature Genetics, 1996
• Velo‐cardio‐facial syndrome and psychotic disorders: Implications for psychiatric genetics
  American Journal of Medical Genetics, 1994
• Genetic study of dopamine D1, D2, and D4 receptors in schizophrenia
  Psychiatry Research, 1994
• Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis.
  Journal of Medical Genetics, 1993
• Catechol O-methyltransferase pharmacogenetics: photoaffinity labelling and Western blot analysis of human liver samples
  Pharmacogenetics, 1993
• Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1→q11.2
  Genomics, 1992
• The current status of the dopamine hypothesis of schizophrenia
  Neuropsychopharmacology, 1988
• The decrease of erythrocyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significance
  Acta Psychiatrica Scandinavica, 1987